ILT6/CD85e/LILRA3 Antibody (293106) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2574C

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 293106
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human LILRA3/CD85e
Arg18-Glu439
Accession # Q8N6C8
Arg18-Glu439
Accession # Q8N6C8
Specificity
Detects human LILRA3/CD85e in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) ILT1, 2, 3, 4, 5, rhLIR6, or rhLIR8 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for ILT6/CD85e/LILRA3 Antibody (293106) [PerCP]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: LILRA3/CD85e
Long Name
Leukocyte Immunoglobulin-like Receptor, Subfamily A (with TM and ITIM Domains), Member 3
Alternate Names
CD85e, HM31, HM43, ILT6, LIR4
Gene Symbol
LILRA3
Additional LILRA3/CD85e Products
Product Documents for ILT6/CD85e/LILRA3 Antibody (293106) [PerCP]
Product Specific Notices for ILT6/CD85e/LILRA3 Antibody (293106) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...